Insider · CIK 0001254748

Henderson Rebecca M

CIK 0001254748 Name as filed on the most recent filing

Filed as Henderson Rebecca M (20)

26 transaction lines · from 20 filings · filed 2007-02-20 to 2021-02-25 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

26 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-02-23 S, Open-market sale Idexx Laboratories Inc /DEIDXX 1,563,840, disposed Open Form 4 filing 0001567619-21-004966
2020-11-10 S, Open-market sale Idexx Laboratories Inc /DEIDXX 2 lines 2,572,742, disposed Open Form 4 filing 0001567619-20-019312
2020-05-13 S, Open-market sale Idexx Laboratories Inc /DEIDXX 2 lines 3,840,052, disposed Open Form 4 filing 0001567619-20-010595
2019-08-14 S, Open-market sale Idexx Laboratories Inc /DEIDXX 1,084,686, disposed Open Form 4 filing 0001567619-19-017356
2019-05-13 S, Open-market sale Idexx Laboratories Inc /DEIDXX 2,123,422, disposed Open Form 4 filing 0001567619-19-011316
2018-11-27 S, Open-market sale Idexx Laboratories Inc /DEIDXX 682,992, disposed Open Form 4 filing 0001567619-18-007117
2017-08-23 S, Open-market sale Idexx Laboratories Inc /DEIDXX 396,269, disposed Open Form 4 filing 0001140361-17-033311
2017-08-22 S, Open-market sale Idexx Laboratories Inc /DEIDXX 394,073, disposed Open Form 4 filing 0001140361-17-033311
2017-05-04 S, Open-market sale Idexx Laboratories Inc /DEIDXX 271,912, disposed Open Form 4 filing 0001140361-17-018657
2017-02-28 S, Open-market sale Idexx Laboratories Inc /DEIDXX 3 lines 943,721, disposed Open Form 4 filing 0001140361-17-010774
2016-08-25 S, Open-market sale Idexx Laboratories Inc /DEIDXX 1,095,953, disposed Open Form 4 filing 0001140361-17-010771
2016-08-25 S, Open-market sale Idexx Laboratories Inc /DEIDXX 1,095,953, disposed Open Form 4 filing 0001140361-16-077987
2015-11-12 S, Open-market sale Idexx Laboratories Inc /DEIDXX 157,299, disposed Open Form 4 filing 0000899243-15-008212
2015-02-05 S, Open-market sale Idexx Laboratories Inc /DEIDXX 458,502, disposed Open Form 4 filing 0001140361-15-004770
2014-02-13 S, Open-market sale Amgen IncAMGN 2,470,680, disposed Open Form 4 filing 0001127602-14-006489
2013-05-17 S, Open-market sale Amgen IncAMGN 2 lines 890,300, disposed Open Form 4 filing 0001127602-13-017602
2012-11-06 S, Open-market sale Idexx Laboratories Inc /DEIDXX 94,510, disposed Open Form 4 filing 0001140361-12-046008
2011-11-28 S, Open-market sale Idexx Laboratories Inc /DEIDXX 357,136, disposed Open Form 4 filing 0001140361-11-055218
2010-06-09 S, Open-market sale Idexx Laboratories Inc /DEIDXX 651,967, disposed Open Form 4 filing 0001140361-10-025261
2010-03-17 S, Open-market sale Idexx Laboratories Inc /DEIDXX 113,531, disposed Open Form 4 filing 0001140361-10-012847
2007-02-16 P, Open-market purchase Idexx Laboratories Inc /DEIDXX 85,510, acquired Open Form 4 filing 0000874716-07-000042

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 25
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. HENDERSON REBECCA M, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001254748

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.